Erweiterte Suche

Anat Ashkenazi ist Mitglied des Vorstands von Varian Medical Systems, Inc. und Maravai Lifesciences Holdings, Inc. und Chief Financial Officer & Senior Vice President bei Eli Lilly & Co. Zuvor war Frau Ashkenazi Chief Financial Officer, Controller & Senior VP bei Lilly Research Laboratories. Anat Ashkenazi erhielt einen Bachelor-Abschluss von der Hebräischen Universität Jerusalem und einen MBA von der Universität Tel-Aviv.

Amit Ashkenazi is Chief Strategy Officer at Artlist, where he is leading the company’s strategy and managing it’s organic and inorganic growth engines.
Amit’s areas of responsibilities also include Corporate Development, Enterprise Sales and partnerships.
Amit is also serving as an advisory board member at Guesty.
Before joining Artlist, Amit served as VP of Business Strategy at Fiverr (NYSE:FVRR) where he led Fiverr’s strategy and managed its strategic initiatives, corporate development and M&As.
Formerly, he was a Partner at Viola Growth, a technology growth capital fund that focuses on investing in Israeli-related global technology companies at their expansion phase.
His investment areas included eCommerce, SaaS, Digital Media, and FinTech.
Prior to joining Viola, Amit worked as a senior consultant at Ernst & Young providing Transaction Advisory Services such as due diligence (buy-side and sell-side), business modeling, and management consulting for both public and private companies in numerous industries.
He also provided Assurance services focusing on high-tech companies.
Amit is a Certified Public Accountant in Israel and holds a BA, Magna Cum Laude, in Business Administration & Accounting from the College of Management and an MBA, Magna Cum Laude, from Tel Aviv University.

Mr. Shlomi Ashkenazi is Co-CEO & Chief Data Scientist at Humanix Data Realization Ltd.
Mr. Ashkenazi was previously employed as Chief Executive Officer by Nextcom Ltd.
(Israel).

Ely E.
Ashkenazi currently works at SDI Technologies, Inc., as Chairman.